NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inteligex Inc.

Inteligex Inc.

Private
Toronto, OntarioHealthcare & Life Scienceshttps://inteligexinc.com/

Last Round

Grant

Dec 10, 2025

Total Funding Raised

$105,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Inteligex Inc. is a regenerative medicine company developing proprietary stem cell-based therapeutics to restore function in individuals with spinal cord injury and other diseases of the Central Nervous System.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

stem cell therapyspinal cord injurySCIregenerative medicineneural stem cellscell therapybioengineered stem cellscentral nervous systemCNSclinical-stage biotechpersonalized medicinedisease progression predictionmedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inteligex Inc. Comparables

Compare Inteligex Inc. with similar companies based on industry and business-model similarity.

Inteligex Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuroplast
79%
NurExone Biologic Inc.
78%
Matricelf
77%

Inteligex Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 10, 2025
AcceleratorJan 21, 2025

Inteligex Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 10, 2025

    Received grant from Give Back Health Innovation Foundation.

  • Jan 21, 2025

    $105K raised from Federal Economic Development Agency and Ontario Genomics.

Inteligex Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inteligex Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inteligex Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Year Founded2018
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.